Recruiting Myocardial Infarction Studies in Chicago
About Myocardial Infarction Clinical Trials in Chicago
Myocardial infarction (heart attack) occurs when blood flow to a part of the heart muscle is blocked, causing tissue damage. It requires emergency treatment to restore blood flow. Long-term management includes dual antiplatelet therapy, statins, beta-blockers, and cardiac rehabilitation.
There are currently 82 myocardial infarction clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 41,271 participants. Research is being sponsored by Massachusetts General Hospital, MPN Research Foundation, Abbott Medical Devices and 60 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myocardial Infarction Clinical Trials in Chicago — FAQ
Are there myocardial infarction clinical trials in Chicago?
Yes, there are 82 myocardial infarction clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chicago?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.
Are clinical trials in Chicago free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.
What myocardial infarction treatments are being tested?
The 82 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for myocardial infarction.
Data updated October 20, 2026 from ClinicalTrials.gov